The main cost drivers in dementia: a systematic review

被引:164
作者
Schaller, Sandra [1 ]
Mauskopf, Josephine [2 ]
Kriza, Christine [1 ]
Wahlster, Philip [1 ]
Kolominsky-Rabas, Peter L. [1 ]
机构
[1] Univ Erlangen Nurnberg, Interdisciplinary Ctr Hlth Technol Assessment HTA, D-91054 Erlangen, Germany
[2] RTI Hlth Solut, Res Triangle Pk, NC USA
关键词
dementia; Alzheimer's disease; cost of illness; economics; care setting; health policy; ALZHEIMER-TYPE DEMENTIA; OF-ILLNESS; ECONOMIC-IMPACT; DEVELOPING-COUNTRIES; DISEASE; CARE; HEALTH; MILD; DEPENDENCY; PREDICTORS;
D O I
10.1002/gps.4198
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
ObjectivesBecause of the increasing prevalence of dementia worldwide, combined with limited healthcare expenditures, a better understanding of the main cost drivers of dementia in different care settings is needed. MethodsA systematic review of cost-of-illness (COI) studies in dementia was conducted from 2003 to 2012, searching the following databases: PubMed (Medline), Cochrane Library, ScienceDirect (Embase) and National Health Service Economic Evaluations Database. Costs (per patient) by care setting were analyzed for total, direct, indirect and informal costs and related to the following: (1) cost perspective and (2) disease severity. ResultsIn total, 27 studies from 14 different healthcare systems were evaluated. In the included studies, total annual costs for dementia of up to $70,911 per patient (mixed setting) were estimated (average estimate of total costs=$30,554). The shares of cost categories in the total costs for dementia indicate significant differences for different care settings. Overall main cost drivers of dementia are informal costs due to home based long term care and nursing home expenditures rather than direct medical costs (inpatient and outpatient services, medication). ConclusionsThe results of this review highlight the significant economic burden of dementia for patients, families and healthcare systems and thus are important for future health policy planning. The significant variation of cost estimates for different care settings underlines the need to understand and address the financial burden of dementia from both perspectives. For health policy planning in dementia, future COI studies should follow a quality standard protocol with clearly defined cost components and separate estimates by care setting and disease severity. Copyright (c) 2014 John Wiley & Sons, Ltd.
引用
收藏
页码:111 / 129
页数:19
相关论文
共 64 条
[1]   Economic impact of dementia in developing countries: an evaluation of costs of Alzheimer-type dementia in Argentina [J].
Allegri, Ricardo F. ;
Butman, Judith ;
Arizaga, Raul L. ;
Machnicki, Gerardo ;
Serrano, Cecilia ;
Toragano, Fernando E. ;
Sarasola, Diego ;
Lon, Leandro .
INTERNATIONAL PSYCHOGERIATRICS, 2007, 19 (04) :705-718
[2]  
Alzheimer Disease International (ADI), 2009, WORLD ALZH REP 2009, P18
[3]  
Alzheimers Disease International (ADI), 2010, WORLD ALZH REP 2010
[4]  
American Psychiatric Association, 2013, DIAGN STAT MAN MENT, DOI DOI 10.1176/APPI.BOOKS.9780890425596
[5]   Cost of disorders of the brain in Europe [J].
Andlin-Sobocki, P ;
Jönsson, B ;
Wittchen, HU ;
Olesen, J .
EUROPEAN JOURNAL OF NEUROLOGY, 2005, 12 :1-+
[6]  
[Anonymous], PREV DEM WORLDW
[7]   Economic cost of Alzheimer disease in Israel [J].
Beeri, MS ;
Werner, P ;
Adar, Z ;
Davidson, M ;
Noy, S .
ALZHEIMER DISEASE & ASSOCIATED DISORDERS, 2002, 16 (02) :73-80
[8]   Cost of illness of Alzheimer's disease: How useful are current estimates? [J].
Bloom, BS ;
de Pouvourville, N ;
Straus, WL .
GERONTOLOGIST, 2003, 43 (02) :158-164
[9]   Usefulness of US cost-of-illness studies in healthcare decision making [J].
Bloom, BS ;
Bruno, DJ ;
Maman, DY ;
Jayadevappa, R .
PHARMACOECONOMICS, 2001, 19 (02) :207-213
[10]  
Brodaty Henry, 2009, Dialogues Clin Neurosci, V11, P217